SARCOIDOSIS, PULMONARY

Clinical trials for SARCOIDOSIS, PULMONARY explained in plain language.

Never miss a new study

Get alerted when new SARCOIDOSIS, PULMONARY trials appear

Sign up with your email to follow new studies for SARCOIDOSIS, PULMONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1 Terminated 1

New drug namilumab tested for lung sarcoidosis – but trial halted early

Disease control Terminated

This study tested namilumab, an experimental drug, in 107 people with chronic pulmonary sarcoidosis, a condition causing lung inflammation. The trial was randomized and placebo-controlled, but it was terminated early. The goal was to see if namilumab could reduce the need for res…

Matched conditions: SARCOIDOSIS, PULMONARY

Phase: PHASE2 • Sponsor: Kinevant Sciences GmbH • Aim: Disease control

Last updated Jun 26, 2026 15:32 UTC

SARCOIDOSIS, PULMONARY

Get alerted when new SARCOIDOSIS, PULMONARY trials appear

New drug namilumab tested for lung sarcoidosis – but trial halted early